{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T11:39:25Z","timestamp":1790163565507,"version":"4.1.0"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,10,19]],"date-time":"2020-10-19T00:00:00Z","timestamp":1603065600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,10,19]],"date-time":"2020-10-19T00:00:00Z","timestamp":1603065600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100005847","name":"Health and Medical Research Fund","doi-asserted-by":"crossref","award":["05163456"],"award-info":[{"award-number":["05163456"]}],"id":[{"id":"10.13039\/501100005847","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Epigenet"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>miR-342-3p, localized to 14q32, is a tumor suppressor miRNA implicated in carcinogenesis. Given the presence of a promotor-associated CpG island for its host gene, <jats:italic>EVL<\/jats:italic>, we hypothesized that intronic miR-342-3p is a tumor suppressor co-regulated with host gene by promoter DNA methylation in B cell lymphoma.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>By bisulfite pyrosequencing-verified methylation-specific PCR (MSP), <jats:italic>EVL\/MIR342<\/jats:italic> methylation was detected in five (50%) lymphoma cell lines but not normal peripheral blood and tonsils. <jats:italic>EVL\/MIR342<\/jats:italic> methylation correlated with repression of both miR-342-3p and EVL in cell lines. In completely methylated SU-DHL-16 cells, 5-AzadC treatment resulted in promoter demethylation and re-expression of miR-342-3p and EVL. In 132 primary lymphoma samples, <jats:italic>EVL\/MIR342<\/jats:italic> was preferentially methylated in B cell lymphomas (<jats:italic>N<\/jats:italic> = 68; 68.7%) than T cell lymphoma (<jats:italic>N<\/jats:italic> = 8; 24.2%) by MSP (<jats:italic>P<\/jats:italic> &lt; 0.0001). Moreover, <jats:italic>EVL\/MIR342<\/jats:italic> methylation was associated with lower miR-342-3p expression in 79 primary NHL (<jats:italic>P<\/jats:italic> = 0.0443). In SU-DHL-16 cells, the tumor suppressor function of miR-342-3p was demonstrated by the inhibition of cellular proliferation and increase of cell death upon over-expression of miR-342-3p. Mechanistically, overexpression of miR-342-3p resulted in a decrease of LC3-II, a biomarker of autophagy, which was pro-survival for SU-DHL-16. Pre-treatment with 3-methyladenine, an autophagy inhibitor, abrogated tumor suppression associated with miR-342-3p overexpression. By luciferase assay, MAP1LC3B, a precursor of LC3-II, was confirmed as a direct target of miR-342-3p. Finally, in SU-DHL-16 cells, overexpression of miR-342-3p downregulated the known target DNMT1, with promoter demethylation and re-expression of tumor suppressor E-cadherin.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Intronic miR-342-3p is co-regulated with its host gene EVL by tumor-specific promoter DNA methylation in B cell lymphoma. The tumor suppressor function of miR-342-3p was mediated via inhibition of pro-survival autophagy by targeting MAP1LC3B and downregulation of DNMT1 with demethylation and re-expression of tumor suppressor genes.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13148-020-00926-1","type":"journal-article","created":{"date-parts":[[2020,10,19]],"date-time":"2020-10-19T12:06:16Z","timestamp":1603109176000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Epigenetic silencing of miR-342-3p in B cell lymphoma and its impact on autophagy"],"prefix":"10.1186","volume":"12","author":[{"given":"Min Yue","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George A.","family":"Calin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kit San","family":"Yuen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong Yan","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2427-915X","authenticated-orcid":false,"given":"Chor Sang","family":"Chim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,10,19]]},"reference":[{"key":"926_CR1","doi-asserted-by":"publisher","first-page":"394","DOI":"10.3322\/caac.21492","volume":"68","author":"F Bray","year":"2018","unstructured":"Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68:394\u2013424.","journal-title":"CA Cancer J Clin"},{"key":"926_CR2","doi-asserted-by":"publisher","first-page":"233","DOI":"10.3389\/fgene.2012.00233","volume":"3","author":"RL Yim","year":"2012","unstructured":"Yim RL, Kwong YL, Wong KY, Chim CS. DNA methylation of tumor suppressive miRNAs in non-Hodgkin's lymphomas. Front Genet. 2012;3:233.","journal-title":"Front Genet"},{"key":"926_CR3","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1309\/AJCP7YLTQPUSDQ5C","volume":"138","author":"J Sun","year":"2012","unstructured":"Sun J, Yang Q, Lu Z, He M, Gao L, Zhu M, Sun L, et al. Distribution of lymphoid neoplasms in China: analysis of 4,638 cases according to the World Health Organization classification. Am J Clin Pathol. 2012;138:429\u201334.","journal-title":"Am J Clin Pathol"},{"key":"926_CR4","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1182\/blood-2003-05-1401","volume":"103","author":"CS Chim","year":"2004","unstructured":"Chim CS, Ma SY, Au WY, Choy C, Lie AK, Liang R, Yau CC, et al. Primary nasal natural killer cell lymphoma: long-term treatment outcome and relationship with the International Prognostic Index. Blood. 2004;103:216\u201321.","journal-title":"Blood."},{"key":"926_CR5","doi-asserted-by":"publisher","first-page":"1148","DOI":"10.1056\/NEJMra072067","volume":"358","author":"M Esteller","year":"2008","unstructured":"Esteller M. Epigenetics in cancer. N Engl J Med. 2008;358:1148\u201359.","journal-title":"N Engl J Med"},{"key":"926_CR6","doi-asserted-by":"publisher","first-page":"3446","DOI":"10.1158\/0008-5472.CAN-15-3278","volume":"76","author":"M Klutstein","year":"2016","unstructured":"Klutstein M, Nejman D, Greenfield R, Cedar H. DNA methylation in cancer and aging. Cancer Res. 2016;76:3446\u201350.","journal-title":"Cancer Res"},{"key":"926_CR7","doi-asserted-by":"publisher","first-page":"1849","DOI":"10.1016\/j.humpath.2007.05.009","volume":"38","author":"CS Chim","year":"2007","unstructured":"Chim CS, Wong KY, Loong F, Lam WW, Srivastava G. Frequent epigenetic inactivation of Rb1 in addition to p15 and p16 in mantle cell and follicular lymphoma. Hum Pathol. 2007;38:1849\u201357.","journal-title":"Hum Pathol"},{"key":"926_CR8","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1038\/sj.leu.2403216","volume":"18","author":"CS Chim","year":"2004","unstructured":"Chim CS, Wong KY, Loong F, Srivastava G. SOCS1 and SHP1 hypermethylation in mantle cell lymphoma and follicular lymphoma: implications for epigenetic activation of the Jak\/STAT pathway. Leukemia. 2004;18:356\u20138.","journal-title":"Leukemia."},{"key":"926_CR9","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1111\/bjh.12262","volume":"161","author":"O Molavi","year":"2013","unstructured":"Molavi O, Wang P, Zak Z, Gelebart P, Belch A, Lai R. Gene methylation and silencing of SOCS3 in mantle cell lymphoma. Br J Haematol. 2013;161:348\u201356.","journal-title":"Br J Haematol"},{"key":"926_CR10","doi-asserted-by":"publisher","first-page":"1609","DOI":"10.1038\/onc.2011.354","volume":"31","author":"P Lopez-Serra","year":"2012","unstructured":"Lopez-Serra P, Esteller M. DNA methylation-associated silencing of tumor-suppressor microRNAs in cancer. Oncogene. 2012;31:1609\u201322.","journal-title":"Oncogene."},{"key":"926_CR11","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1038\/nrc1840","volume":"6","author":"A Esquela-Kerscher","year":"2006","unstructured":"Esquela-Kerscher A, Slack FJ. Oncomirs - microRNAs with a role in cancer. Nat Rev Cancer. 2006;6:259\u201369.","journal-title":"Nat Rev Cancer"},{"key":"926_CR12","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.cell.2009.01.002","volume":"136","author":"DP Bartel","year":"2009","unstructured":"Bartel DP. MicroRNAs: target recognition and regulatory functions. Cell. 2009;136:215\u201333.","journal-title":"Cell."},{"key":"926_CR13","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1038\/nrc1997","volume":"6","author":"GA Calin","year":"2006","unstructured":"Calin GA, Croce CM. MicroRNA signatures in human cancers. Nat Rev Cancer. 2006;6:857\u201366.","journal-title":"Nat Rev Cancer"},{"key":"926_CR14","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/1756-8722-6-16","volume":"6","author":"KY Wong","year":"2013","unstructured":"Wong KY, Yim RL, Kwong YL, Leung CY, Hui PK, Cheung F, Liang R, et al. Epigenetic inactivation of the MIR129-2 in hematological malignancies. J Hematol Oncol. 2013;6:16.","journal-title":"J Hematol Oncol"},{"key":"926_CR15","doi-asserted-by":"publisher","first-page":"9770","DOI":"10.18632\/oncotarget.2390","volume":"5","author":"RL Yim","year":"2014","unstructured":"Yim RL, Wong KY, Kwong YL, Loong F, Leung CY, Chu R, Lam WW, et al. Methylation of miR-155-3p in mantle cell lymphoma and other non-Hodgkin's lymphomas. Oncotarget. 2014;5:9770\u201382.","journal-title":"Oncotarget."},{"key":"926_CR16","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1093\/carcin\/bgq033","volume":"31","author":"CS Chim","year":"2010","unstructured":"Chim CS, Wong KY, Qi Y, Loong F, Lam WL, Wong LG, Jin DY, et al. Epigenetic inactivation of the miR-34a in hematological malignancies. Carcinogenesis. 2010;31:745\u201350.","journal-title":"Carcinogenesis."},{"key":"926_CR17","doi-asserted-by":"publisher","first-page":"e19027","DOI":"10.1371\/journal.pone.0019027","volume":"6","author":"KY Wong","year":"2011","unstructured":"Wong KY, So CC, Loong F, Chung LP, Lam WW, Liang R, Li GK, et al. Epigenetic inactivation of the miR-124-1 in haematological malignancies. PLoS One. 2011;6:e19027.","journal-title":"PLoS One"},{"key":"926_CR18","doi-asserted-by":"publisher","first-page":"jcs230508","DOI":"10.1242\/jcs.230508","volume":"133","author":"KM Wilton","year":"2019","unstructured":"Wilton KM, Overlee BL, Billadeau DD. NKG2D-DAP10 signaling recruits EVL to the cytotoxic synapse to generate F-actin and promote NK cell cytotoxicity. J Cell Sci. 2019;133:jcs230508.","journal-title":"J Cell Sci"},{"key":"926_CR19","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1146\/annurev.cellbio.19.050103.103356","volume":"19","author":"M Krause","year":"2003","unstructured":"Krause M, Dent EW, Bear JE, Loureiro JJ, Gertler FB. Ena\/VASP proteins: regulators of the actin cytoskeleton and cell migration. Annu Rev Cell Dev Biol. 2003;19:541\u201364.","journal-title":"Annu Rev Cell Dev Biol"},{"key":"926_CR20","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1016\/S0962-8924(03)00130-2","volume":"13","author":"AV Kwiatkowski","year":"2003","unstructured":"Kwiatkowski AV, Gertler FB, Loureiro JJ. Function and regulation of Ena\/VASP proteins. Trends Cell Biol. 2003;13:386\u201392.","journal-title":"Trends Cell Biol"},{"key":"926_CR21","first-page":"1015","volume":"19","author":"LD Hu","year":"2008","unstructured":"Hu LD, Zou HF, Zhan SX, Cao KM. EVL (Ena\/VASP-like) expression is up-regulated in human breast cancer and its relative expression level is correlated with clinical stages. Oncol Rep. 2008;19:1015\u201320.","journal-title":"Oncol Rep"},{"key":"926_CR22","doi-asserted-by":"publisher","first-page":"7164","DOI":"10.1038\/sj.onc.1205654","volume":"21","author":"HM Fathallah-Shaykh","year":"2002","unstructured":"Fathallah-Shaykh HM, Rigen M, Zhao LJ, Bansal K, He B, Engelhard HH, Cerullo L, et al. Mathematical modeling of noise and discovery of genetic expression classes in gliomas. Oncogene. 2002;21:7164\u201374.","journal-title":"Oncogene."},{"key":"926_CR23","doi-asserted-by":"publisher","first-page":"3298","DOI":"10.1016\/j.febslet.2014.07.020","volume":"588","author":"XR Li","year":"2014","unstructured":"Li XR, Chu HJ, Lv T, Wang L, Kong SF, Dai SZ. miR-342-3p suppresses proliferation, migration and invasion by targeting FOXM1 in human cervical cancer. FEBS Lett. 2014;588:3298\u2013307.","journal-title":"FEBS Lett"},{"key":"926_CR24","doi-asserted-by":"publisher","first-page":"3880","DOI":"10.1038\/onc.2008.10","volume":"27","author":"WM Grady","year":"2008","unstructured":"Grady WM, Parkin RK, Mitchell PS, Lee JH, Kim YH, Tsuchiya KD, Washington MK, et al. Epigenetic silencing of the intronic microRNA hsa-miR-342 and its host gene EVL in colorectal cancer. Oncogene. 2008;27:3880\u20138.","journal-title":"Oncogene."},{"key":"926_CR25","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1093\/carcin\/bgr081","volume":"32","author":"H Wang","year":"2011","unstructured":"Wang H, Wu J, Meng X, Ying X, Zuo Y, Liu R, Pan Z, et al. MicroRNA-342 inhibits colorectal cancer cell proliferation and invasion by directly targeting DNA methyltransferase 1. Carcinogenesis. 2011;32:1033\u201342.","journal-title":"Carcinogenesis."},{"key":"926_CR26","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1016\/j.bbrc.2014.12.119","volume":"457","author":"L Zhao","year":"2015","unstructured":"Zhao L, Zhang Y. miR-342-3p affects hepatocellular carcinoma cell proliferation via regulating NF-kappaB pathway. Biochem Biophys Res Commun. 2015;457:370\u20137.","journal-title":"Biochem Biophys Res Commun"},{"key":"926_CR27","first-page":"1464","volume":"36","author":"MC Tai","year":"2015","unstructured":"Tai MC, Kajino T, Nakatochi M, Arima C, Shimada Y, Suzuki M, Miyoshi H, et al. miR-342-3p regulates MYC transcriptional activity via direct repression of E2F1 in human lung cancer. Carcinogenesis. 2015;36:1464\u201373.","journal-title":"Carcinogenesis."},{"key":"926_CR28","doi-asserted-by":"publisher","first-page":"18594","DOI":"10.18632\/oncotarget.7617","volume":"7","author":"E Crippa","year":"2016","unstructured":"Crippa E, Folini M, Pennati M, Zaffaroni N, Pierotti MA, Gariboldi M. miR-342 overexpression results in a synthetic lethal phenotype in BRCA1-mutant HCC1937 breast cancer cells. Oncotarget. 2016;7:18594\u2013604.","journal-title":"Oncotarget."},{"key":"926_CR29","doi-asserted-by":"publisher","first-page":"4947","DOI":"10.1158\/1078-0432.CCR-16-0360","volume":"22","author":"W Weng","year":"2016","unstructured":"Weng W, Okugawa Y, Toden S, Toiyama Y, Kusunoki M, Goel A. FOXM1 and FOXQ1 are promising prognostic biomarkers and novel targets of tumor-suppressive miR-342 in human colorectal cancer. Clin Cancer Res. 2016;22:4947\u201357.","journal-title":"Clin Cancer Res"},{"key":"926_CR30","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1038\/nrc.2017.53","volume":"17","author":"JMM Levy","year":"2017","unstructured":"Levy JMM, Towers CG, Thorburn A. Targeting autophagy in cancer. Nat Rev Cancer. 2017;17:528\u201342.","journal-title":"Nat Rev Cancer"},{"key":"926_CR31","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1038\/nmeth.3485","volume":"12","author":"H Dweep","year":"2015","unstructured":"Dweep H, Gretz N. miRWalk2.0: a comprehensive atlas of microRNA-target interactions. Nat Methods. 2015;12:697.","journal-title":"Nat Methods"},{"key":"926_CR32","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1186\/1476-4598-12-173","volume":"12","author":"LQ Wang","year":"2013","unstructured":"Wang LQ, Kwong YL, Kho CS, Wong KF, Wong KY, Ferracin M, Calin GA, et al. Epigenetic inactivation of miR-9 family microRNAs in chronic lymphocytic leukemia--implications on constitutive activation of NFkappaB pathway. Mol Cancer. 2013;12:173.","journal-title":"Mol Cancer"},{"key":"926_CR33","doi-asserted-by":"publisher","first-page":"1455","DOI":"10.4161\/cc.6.12.4408","volume":"6","author":"A Lujambio","year":"2007","unstructured":"Lujambio A, Esteller M. CpG island hypermethylation of tumor suppressor microRNAs in human cancer. Cell Cycle. 2007;6:1455\u20139.","journal-title":"Cell Cycle"},{"key":"926_CR34","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1136\/jclinpath-2017-204501","volume":"71","author":"Z Li","year":"2018","unstructured":"Li Z, Wong KY, Chan GC, Chim CS. Epigenetic silencing of LPP\/miR-28 in multiple myeloma. J Clin Pathol. 2018;71:253\u20138.","journal-title":"J Clin Pathol"},{"key":"926_CR35","doi-asserted-by":"publisher","first-page":"44422","DOI":"10.18632\/oncotarget.6251","volume":"6","author":"LQ Wang","year":"2015","unstructured":"Wang LQ, Wong KY, Rosen A, Chim CS. Epigenetic silencing of tumor suppressor miR-3151 contributes to Chinese chronic lymphocytic leukemia by constitutive activation of MADD\/ERK and PIK3R2\/AKT signaling pathways. Oncotarget. 2015;6:44422\u201336.","journal-title":"Oncotarget."},{"key":"926_CR36","doi-asserted-by":"publisher","first-page":"1902","DOI":"10.1101\/gr.2722704","volume":"14","author":"A Rodriguez","year":"2004","unstructured":"Rodriguez A, Griffiths-Jones S, Ashurst JL, Bradley A. Identification of mammalian microRNA host genes and transcription units. Genome Res. 2004;14:1902\u201310.","journal-title":"Genome Res"},{"key":"926_CR37","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1261\/rna.7240905","volume":"11","author":"S Baskerville","year":"2005","unstructured":"Baskerville S, Bartel DP. Microarray profiling of microRNAs reveals frequent coexpression with neighboring miRNAs and host genes. Rna. 2005;11:241\u20137.","journal-title":"Rna."},{"key":"926_CR38","volume-title":"WHO classification of tumours of haematopoietic and lymphoid tissues","author":"SH Swerdlow","year":"2008","unstructured":"Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, Thiele J, et al. WHO classification of tumours of haematopoietic and lymphoid tissues. Lyon: International Agency for Research on Cancer; 2008."},{"key":"926_CR39","doi-asserted-by":"publisher","first-page":"e6986","DOI":"10.1371\/journal.pone.0006986","volume":"4","author":"JI Martin-Subero","year":"2009","unstructured":"Martin-Subero JI, Ammerpohl O, Bibikova M, Wickham-Garcia E, Agirre X, Alvarez S, Bruggemann M, et al. A comprehensive microarray-based DNA methylation study of 367 hematological neoplasms. PLoS One. 2009;4:e6986.","journal-title":"PLoS One"},{"key":"926_CR40","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1056\/NEJMra1205406","volume":"368","author":"AM Choi","year":"2013","unstructured":"Choi AM, Ryter SW, Levine B. Autophagy in human health and disease. N Engl J Med. 2013;368:651\u201362.","journal-title":"N Engl J Med"},{"key":"926_CR41","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1016\/j.cmet.2017.04.004","volume":"25","author":"AC Kimmelman","year":"2017","unstructured":"Kimmelman AC, White E. Autophagy and tumor metabolism. Cell Metab. 2017;25:1037\u201343.","journal-title":"Cell Metab"},{"key":"926_CR42","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1038\/cdd.2010.191","volume":"18","author":"R Kang","year":"2011","unstructured":"Kang R, Zeh HJ, Lotze MT, Tang D. The Beclin 1 network regulates autophagy and apoptosis. Cell Death Differ. 2011;18:571\u201380.","journal-title":"Cell Death Differ"},{"key":"926_CR43","doi-asserted-by":"publisher","first-page":"15077","DOI":"10.1073\/pnas.2436255100","volume":"100","author":"Z Yue","year":"2003","unstructured":"Yue Z, Jin S, Yang C, Levine AJ, Heintz N. Beclin 1, an autophagy gene essential for early embryonic development, is a haploinsufficient tumor suppressor. Proc Natl Acad Sci U S A. 2003;100:15077\u201382.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"926_CR44","doi-asserted-by":"publisher","first-page":"6410","DOI":"10.1158\/0008-5472.CAN-16-0595","volume":"76","author":"H Zhang","year":"2016","unstructured":"Zhang H, Chen Z, Miranda RN, Medeiros LJ, McCarty N. TG2 and NF-kappaB signaling coordinates the survival of mantle cell lymphoma cells via IL6-mediated autophagy. Cancer Res. 2016;76:6410\u201323.","journal-title":"Cancer Res"},{"key":"926_CR45","doi-asserted-by":"publisher","first-page":"1763","DOI":"10.1158\/0008-5472.CAN-11-3671","volume":"72","author":"V Kovaleva","year":"2012","unstructured":"Kovaleva V, Mora R, Park YJ, Plass C, Chiramel AI, Bartenschlager R, Dohner H, et al. miRNA-130a targets ATG2B and DICER1 to inhibit autophagy and trigger killing of chronic lymphocytic leukemia cells. Cancer Res. 2012;72:1763\u201372.","journal-title":"Cancer Res"},{"key":"926_CR46","doi-asserted-by":"publisher","first-page":"2517","DOI":"10.1159\/000492690","volume":"48","author":"D Lu","year":"2018","unstructured":"Lu D, Yang C, Zhang Z, Cong Y, Xiao M. Knockdown of Linc00515 inhibits multiple myeloma autophagy and chemoresistance by upregulating miR-140-5p and downregulating ATG14. Cell Physiol Biochem. 2018;48:2517\u201327.","journal-title":"Cell Physiol Biochem"},{"key":"926_CR47","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.molcel.2007.06.017","volume":"27","author":"A Grimson","year":"2007","unstructured":"Grimson A, Farh KK, Johnston WK, Garrett-Engele P, Lim LP, Bartel DP. MicroRNA targeting specificity in mammals: determinants beyond seed pairing. Mol Cell. 2007;27:91\u2013105.","journal-title":"Mol Cell"},{"key":"926_CR48","first-page":"819","volume":"15","author":"M Hart","year":"2018","unstructured":"Hart M, Kern F, Backes C, Rheinheimer S, Fehlmann T, Keller A, Meese E. The deterministic role of 5-mers in microRNA-gene targeting. RNA Biol. 2018;15:819\u201325.","journal-title":"RNA Biol"},{"key":"926_CR49","doi-asserted-by":"publisher","first-page":"2307","DOI":"10.3892\/ol.2015.3038","volume":"9","author":"H Zhao","year":"2015","unstructured":"Zhao H, Zhang LE, Guo S, Yuan T, Xia B, Zhang L, Zhang Y. Overexpression of DNA methyltransferase 1 as a negative independent prognostic factor in primary gastrointestinal diffuse large B-cell lymphoma treated with CHOP-like regimen and rituximab. Oncol Lett. 2015;9:2307\u201312.","journal-title":"Oncol Lett"},{"key":"926_CR50","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/j.yexmp.2015.03.006","volume":"98","author":"MC Robaina","year":"2015","unstructured":"Robaina MC, Mazzoccoli L, Arruda VO, Reis FR, Apa AG, de Rezende LM, Klumb CE. Deregulation of DNMT1, DNMT3B and miR-29s in Burkitt lymphoma suggests novel contribution for disease pathogenesis. Exp Mol Pathol. 2015;98:200\u20137.","journal-title":"Exp Mol Pathol"},{"key":"926_CR51","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1002\/hep.23660","volume":"52","author":"J Huang","year":"2010","unstructured":"Huang J, Wang Y, Guo Y, Sun S. Down-regulated microRNA-152 induces aberrant DNA methylation in hepatitis B virus-related hepatocellular carcinoma by targeting DNA methyltransferase 1. Hepatology. 2010;52:60\u201370.","journal-title":"Hepatology."},{"key":"926_CR52","doi-asserted-by":"publisher","first-page":"7274","DOI":"10.1038\/onc.2008.333","volume":"27","author":"Q Cao","year":"2008","unstructured":"Cao Q, Yu J, Dhanasekaran SM, Kim JH, Mani RS, Tomlins SA, Mehra R, et al. Repression of E-cadherin by the polycomb group protein EZH2 in cancer. Oncogene. 2008;27:7274\u201384.","journal-title":"Oncogene."},{"key":"926_CR53","doi-asserted-by":"publisher","first-page":"492","DOI":"10.4161\/epi.27650","volume":"9","author":"AM Kaz","year":"2014","unstructured":"Kaz AM, Wong CJ, Dzieciatkowski S, Luo Y, Schoen RE, Grady WM. Patterns of DNA methylation in the normal colon vary by anatomical location, gender, and age. Epigenetics. 2014;9:492\u2013502.","journal-title":"Epigenetics."},{"key":"926_CR54","doi-asserted-by":"publisher","first-page":"417","DOI":"10.2217\/epi.11.65","volume":"3","author":"JA Rusiecki","year":"2011","unstructured":"Rusiecki JA, Al-Nabhani M, Tarantini L, Chen L, Baccarelli A, Al-Moundhri MS. Global DNA methylation and tumor suppressor gene promoter methylation and gastric cancer risk in an Omani Arab population. Epigenomics. 2011;3:417\u201329.","journal-title":"Epigenomics."}],"container-title":["Clinical Epigenetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13148-020-00926-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13148-020-00926-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13148-020-00926-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,18]],"date-time":"2021-10-18T23:49:39Z","timestamp":1634600979000},"score":1,"resource":{"primary":{"URL":"https:\/\/clinicalepigeneticsjournal.biomedcentral.com\/articles\/10.1186\/s13148-020-00926-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,19]]},"references-count":54,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["926"],"URL":"https:\/\/doi.org\/10.1186\/s13148-020-00926-1","relation":{},"ISSN":["1868-7075","1868-7083"],"issn-type":[{"value":"1868-7075","type":"print"},{"value":"1868-7083","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,10,19]]},"assertion":[{"value":"27 June 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 August 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 October 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study has been approved by the Institutional Review Board of Queen Mary Hospital (UW 05-269 T\/932) and written informed consent has been obtained from patients for the participation of this study.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"We have obtained consents from patients for the publication of this report and any accompanying data or images.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"150"}}